Literature DB >> 17963305

Genetic polymorphisms of ADH2 and ALDH2 association with esophageal cancer risk in southwest China.

Shu-Juan Yang1, Hua-Yu Wang, Xiao-Qing Li, Hui-Zhang Du, Can-Jie Zheng, Huai-Gong Chen, Xiao-Yan Mu, Chun-Xia Yang.   

Abstract

AIM: To evaluate the impact of alcohol dehydrogenase 2 (ADH2) and aldehyde dehydrogenase 2 (ALDH2) polymorphisms on esophageal cancer risk.
METHODS: One hundred and ninety-one esophageal cancer patients and 198 healthy controls from Yanting County were enrolled in this study. ADH2 and ALDH2 genotypes were examined by polymerase-chain-reaction with the confronting-two-pair-primer (PCR-CTPP) method. Unconditional logistic regression was used to calculate the odds ratios (OR) and 95% confidence interval (95% CI).
RESULTS: Both ADH2 1 allele and ALDH2 1/ 2 allele showed an increased risk of developing esophageal cancer. The adjusted OR (95% CI) for ADH2 1 allele compared with ADH2 2/ 2 was 1.65 (95% CI = 1.02-2.68) and 1.67 (95% CI = 1.02-2.72) for ALDH2 1/ 2 compared with ALDH2 1/ 1. A significant interaction between ALDH2 and drinking was detected regarding esophageal cancer risk, the OR was 1.83 (95% CI = 1.13-2.95). Furthermore, when compared with ADH2 2/ 2 and ALDH2 1/ 1 carriers, ADH2 1 and ALDH2 2 carriers showed an elevated risk of developing esophageal cancer among non-alcohol drinkers (OR = 2.46, 95% CI = 0.98-6.14), and a significantly elevated risk of developing esophageal cancer among alcohol drinkers among alcohol drinkers (OR = 9.86, 95% CI = 3.10-31.38).
CONCLUSION: ADH2 and ALDH2 genotypes are associated with esophageal cancer risk. ADH2 1 allele and ALDH2 2 allele carriers have a much higher risk of developing esophageal cancer, especially among alcohol drinkers.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17963305      PMCID: PMC4171265          DOI: 10.3748/wjg.v13.i43.5760

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  27 in total

Review 1.  Epidemiologic trends in esophageal and gastric cancer in the United States.

Authors:  Linda Morris Brown; Susan S Devesa
Journal:  Surg Oncol Clin N Am       Date:  2002-04       Impact factor: 3.495

2.  The evolution and population genetics of the ALDH2 locus: random genetic drift, selection, and low levels of recombination.

Authors:  Hiroki Oota; Andrew J Pakstis; Batsheva Bonne-Tamir; David Goldman; Elena Grigorenko; Sylvester L B Kajuna; Nganyirwa J Karoma; Selemani Kungulilo; Ru-Band Lu; Kunle Odunsi; Friday Okonofua; Olga V Zhukova; Judith R Kidd; Kenneth K Kidd
Journal:  Ann Hum Genet       Date:  2004-03       Impact factor: 1.670

3.  Genetic polymorphisms of alcohol and aldehyde dehydrogenases and glutathione S-transferase M1 and drinking, smoking, and diet in Japanese men with esophageal squamous cell carcinoma.

Authors:  Akira Yokoyama; Hoichi Kato; Tetsuji Yokoyama; Toshimasa Tsujinaka; Manabu Muto; Tai Omori; Tatsumasa Haneda; Yoshiya Kumagai; Hiroyasu Igaki; Masako Yokoyama; Hiroshi Watanabe; Haruhiko Fukuda; Haruko Yoshimizu
Journal:  Carcinogenesis       Date:  2002-11       Impact factor: 4.944

4.  Gene-environment interaction between an aldehyde dehydrogenase-2 (ALDH2) polymorphism and alcohol consumption for the risk of esophageal cancer.

Authors:  K Matsuo; N Hamajima; M Shinoda; S Hatooka; M Inoue; T Takezaki; K Tajima
Journal:  Carcinogenesis       Date:  2001-06       Impact factor: 4.944

5.  Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and human esophageal squamous cell carcinoma susceptibility.

Authors:  H Hori; T Kawano; M Endo; Y Yuasa
Journal:  J Clin Gastroenterol       Date:  1997-12       Impact factor: 3.062

6.  Allele Frequencies of 25 Polymorphisms Pertaining to Cancer Risk for Japanese, Koreans and Chinese.

Authors:  Nobuyuki Hamajima; Toshiro Takezaki; Kazuo Tajima
Journal:  Asian Pac J Cancer Prev       Date:  2002

7.  Esophageal cancer and aldehyde dehydrogenase-2 genotypes in Japanese males.

Authors:  A Yokoyama; T Muramatsu; T Ohmori; S Higuchi; M Hayashida; H Ishii
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1996-02       Impact factor: 4.254

8.  Alcohol, tobacco, diet, mate drinking, and esophageal cancer in Argentina.

Authors:  R Castelletto; X Castellsague; N Muñoz; J Iscovich; N Chopita; A Jmelnitsky
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1994 Oct-Nov       Impact factor: 4.254

Review 9.  A mutagenicity assessment of acetaldehyde.

Authors:  V L Dellarco
Journal:  Mutat Res       Date:  1988-01       Impact factor: 2.433

10.  Human liver alcohol dehydrogenase: purification and kinetic characterization of the beta 2 beta 2, beta 2 beta 1, alpha beta 2, and beta 2 gamma 1 "Oriental" isoenzymes.

Authors:  S J Yin; W F Bosron; L J Magnes; T K Li
Journal:  Biochemistry       Date:  1984-11-20       Impact factor: 3.162

View more
  31 in total

1.  Genetic polymorphisms in cytochrome P4502E1, alcohol and aldehyde dehydrogenases and the risk of esophageal squamous cell carcinoma in Gansu Chinese males.

Authors:  Yan-Mei Guo; Qin Wang; Yan-Zhen Liu; Huei-Min Chen; Zhi Qi; Qing-Hong Guo
Journal:  World J Gastroenterol       Date:  2008-03-07       Impact factor: 5.742

2.  ALDH2(E487K) mutation increases protein turnover and promotes murine hepatocarcinogenesis.

Authors:  Shengfang Jin; Jiang Chen; Lizao Chen; Gavin Histen; Zhizhong Lin; Stefan Gross; Jeffrey Hixon; Yue Chen; Charles Kung; Yiwei Chen; Yufei Fu; Yuxuan Lu; Hui Lin; Xiujun Cai; Hua Yang; Rob A Cairns; Marion Dorsch; Shinsan M Su; Scott Biller; Tak W Mak; Yong Cang
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-06       Impact factor: 11.205

3.  Association of colorectal cancer susceptibility variants with esophageal cancer in a Chinese population.

Authors:  Ting-Ting Geng; Xiao-Jie Xun; Sen Li; Tian Feng; Li-Ping Wang; Tian-Bo Jin; Peng Hou
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

4.  Gene-environment interactions on the risk of esophageal cancer among Asian populations with the G48A polymorphism in the alcohol dehydrogenase-2 gene: a meta-analysis.

Authors:  Long Zhang; Yingjiu Jiang; Qingcheng Wu; Qiang Li; Dan Chen; Ling Xu; Cheng Zhang; Min Zhang; Ling Ye
Journal:  Tumour Biol       Date:  2014-01-21

5.  ADH1B Arg47His polymorphism is associated with esophageal cancer risk in high-incidence Asian population: evidence from a meta-analysis.

Authors:  Guohong Zhang; Ruiqin Mai; Bo Huang
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

6.  Confronting two-pair primer design for enzyme-free SNP genotyping based on a genetic algorithm.

Authors:  Cheng-Hong Yang; Yu-Huei Cheng; Li-Yeh Chuang; Hsueh-Wei Chang
Journal:  BMC Bioinformatics       Date:  2010-10-13       Impact factor: 3.169

7.  Refined geographic distribution of the oriental ALDH2*504Lys (nee 487Lys) variant.

Authors:  Hui Li; Svetlana Borinskaya; Kimio Yoshimura; Nina Kal'ina; Andrey Marusin; Vadim A Stepanov; Zhendong Qin; Shagufta Khaliq; Mi-Young Lee; Yajun Yang; Aisha Mohyuddin; David Gurwitz; Syed Qasim Mehdi; Evgeny Rogaev; Li Jin; Nikolay K Yankovsky; Judith R Kidd; Kenneth K Kidd
Journal:  Ann Hum Genet       Date:  2009-05       Impact factor: 1.670

8.  Polymorphisms of alcohol dehydrogenase-2 and aldehyde dehydrogenase-2 and esophageal cancer risk in Southeast Chinese males.

Authors:  Jian-Hua Ding; Su-Ping Li; Hai-Xia Cao; Jian-Zhong Wu; Chang-Ming Gao; Ping Su; Yan-Ting Liu; Jian-Nong Zhou; Jun Chang; Gen-Hong Yao
Journal:  World J Gastroenterol       Date:  2009-05-21       Impact factor: 5.742

Review 9.  The alcohol flushing response: an unrecognized risk factor for esophageal cancer from alcohol consumption.

Authors:  Philip J Brooks; Mary-Anne Enoch; David Goldman; Ting-Kai Li; Akira Yokoyama
Journal:  PLoS Med       Date:  2009-03-24       Impact factor: 11.069

10.  Family history of cancer and risk for esophageal and gastric cancer in Shanxi, China.

Authors:  Ying Gao; Nan Hu; XiaoYou Han; Carol Giffen; Ti Ding; Alisa Goldstein; Philip Taylor
Journal:  BMC Cancer       Date:  2009-08-05       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.